FILE:HUM/HUM-8K-20120904162140.txt.gz
EVENTS:	Regulation FD Disclosure
TEXT:
ITEM: Regulation FD Disclosure
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
      Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (General Instruction A.2. below):
see
 
           Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
o
          Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
o
         Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
o
         Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
o
 
 
 
 
 
 
 
Item 7.01                      Regulation FD Disclosure
 
 
Members of Humana Inc.s senior management team are scheduled to meet with investors at various times between September 5, 2012 and September 18, 2012.  During such meetings, Humanas management expects to reaffirm its guidance of $6.90 to $7.10 in diluted earnings per common share (EPS) for the year ending December 31, 2012.  This EPS guidance is consistent with that issued in Humanas press release dated July 30, 2012, and subsequently reiterated in investor presentations posted to the Investor Relations section of its web site (www.humana.com).  The date and time of each presentation during the period discussed in this filing are available via the Investor Relations section of Humanas web site.
 
 
 
 
 
 
 
 
 
 
 
Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this Report to be signed on its behalf by the undersigned hereunto duly authorized.
 
 
 
 
Dated:           September 4, 2012


